Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region

Description

List of Tables

The biomarkers market size is expected to reach USD 146.78 Billion by 2034, according to a new study by Polaris Market Research. The report "Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.

The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.

Biomarkers Market Report Highlights

Based on research area, the genomics segment held the leading market position in 2024, primarily due to its extensive application in detecting genetic variations, assessing disease susceptibility, and enabling precision medicine approaches across therapeutic areas.

In terms of technology, the next-generation sequencing technology is anticipated to experience the most rapid market expansion during the forecast period. This accelerated growth reflects NGS's unparalleled capacity for high-throughput genomic analysis, which facilitates comprehensive biomarker discovery

North America captured the largest share of the biomarkers market in 2024, a position supported by the region's concentration of innovative biopharmaceutical firms, advanced diagnostic laboratories, and substantial investments in precision medicine research and development initiatives.

The Asia Pacific biomarkers market is forecast to demonstrate the highest growth rate during the projection period, driven by rapid improvements in healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and expanding capabilities in biomedical research across emerging economies in the region.

A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMerieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.

Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Safety Biomarkers

Efficacy Biomarkers

Validation Biomarkers

By Research Area Outlook (Revenue, USD Billion, 2020-2034)

Genomics

Proteomics

Metabolomics

Other Research Areas

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Immunoassays

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Mass Spectrometry

Chromatography

Other Technologies

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Infectious Disease

Immunological Disorders

Neurological Disorders

Cardiovascular Disorders

Other Disease Indications

By Application Outlook (Revenue, USD Billion, 2020-2034)

Clinical Diagnostics

Drug Discovery & Development

Personalized Medicine

Clinical Research

Other Application

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5934

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Biomarkers Market Insights

4.1. Biomarkers Market - Market Snapshot
4.2. Biomarkers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Chronic Diseases
  - 4.2.1.2. Advancements in Genomics and Proteomics
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Biomarker Validation and Development
  - 4.2.2.2. Regulatory Uncertainty and Lengthy Approval Processes
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Biomarkers Market Trends
4.6. Value Chain Analysis

5. Global Biomarkers Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
5.3. Safety Biomarkers
- 5.3.1. Global Biomarkers Market, by Safety Biomarkers, by Region, 2020-2034 (USD Billion)
5.4. Efficacy Biomarkers
- 5.4.2. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
5.5. Validation Biomarkers
- 5.5.1. Global Biomarkers Market, by Validation Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Biomarkers Market, by Research Area

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
6.3. Genomics
- 6.3.1. Global Biomarkers Market, by Genomics, by Region, 2020-2034 (USD Billion)
6.4. Proteomics
- 6.4.1. Global Biomarkers Market, by Proteomics, by Region, 2020-2034 (USD Billion)
6.5. Metabolomics
- 6.5.1. Global Biomarkers Market, by Metabolomics, by Region, 2020-2034 (USD Billion)
6.6. Other Research Areas
- 6.6.1. Global Biomarkers Market, by Other Research Areas, by Region, 2020-2034 (USD Billion)

7. Global Biomarkers Market, by Technology

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
7.3. Immunoassays
- 7.3.1. Global Biomarkers Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
7.4. Next-Generation Sequencing (NGS)
- 7.4.1. Global Biomarkers Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
7.5. Polymerase Chain Reaction (PCR)
- 7.5.1. Global Biomarkers Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD Billion)
7.6. Mass Spectrometry
- 7.6.1. Global Biomarkers Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
7.7. Chromatography
- 7.7.1. Global Biomarkers Market, by Chromatography, by Region, 2020-2034 (USD Billion)
7.8. Other Technologies
- 7.8.1. Global Biomarkers Market, by Other Technologies, by Region, 2020-2034 (USD Billion)

8. Global Biomarkers Market, by Disease Indication

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
8.3. Cancer
- 8.3.1. Global Biomarkers Market, by Cancer, by Region, 2020-2034 (USD Billion)
8.4. Infectious Disease
- 8.4.1. Global Biomarkers Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
8.5. Immunological Disorders
- 8.5.1. Global Biomarkers Market, by Immunological Disorders, by Region, 2020-2034 (USD Billion)
8.6. Government & Public Sector
- 8.6.1. Global Biomarkers Market, by Government & Public Sector, by Region, 2020-2034 (USD Billion)
8.7. Neurological Disorders
- 8.7.1. Global Biomarkers Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
8.8. Cardiovascular Disorders
- 8.8.1. Global Biomarkers Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
8.9. Other Disease Indications
- 8.9.1. Global Biomarkers Market, by Other Disease Indications, by Region, 2020-2034 (USD Billion)

9. Global Biomarkers Market, by Application

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
9.3. Clinical Diagnostics
- 9.3.1. Global Biomarkers Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
9.4. Drug Discovery & Development
- 9.4.1. Global Biomarkers Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Billion)
9.5. Personalized Medicine
- 9.5.1. Global Biomarkers Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
9.6. Clinical Research
- 9.6.1. Global Biomarkers Market, by Clinical Research, by Region, 2020-2034 (USD Billion)
9.7. Other Application
- 9.7.1. Global Biomarkers Market, by Other Application, by Region, 2020-2034 (USD Billion)

10. Global Biomarkers Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Biomarkers Market - North America
- 10.3.1. North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
- 10.3.3. North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
- 10.3.4. North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.3.5. North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.3.6. Biomarkers Market - U.S.
  - 10.3.6.1. U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.3.6.2. U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.3.6.3. U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.3.6.4. U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.3.6.5. U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.3.7. Biomarkers Market - Canada
  - 10.3.7.1. Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.3.7.2. Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.3.7.3. Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.3.7.4. Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.3.7.5. Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
10.4. Biomarkers Market - Europe
- 10.4.1. Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
- 10.4.3. Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
- 10.4.4. Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.4.5. Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.6. Biomarkers Market - UK
  - 10.4.6.1. UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.7. Biomarkers Market - France
  - 10.4.7.1. France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.8. Biomarkers Market - Germany
  - 10.4.8.1. Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.9. Biomarkers Market - Italy
  - 10.4.9.1. Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.10. Biomarkers Market - Spain
  - 10.4.10.1. Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.11. Biomarkers Market - Netherlands
  - 10.4.11.1. Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.12. Biomarkers Market - Russia
  - 10.4.12.1. Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.4.13. Biomarkers Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
10.5. Biomarkers Market - Asia Pacific
- 10.5.1. Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.6. Biomarkers Market - China
  - 10.5.6.1. China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.7. Biomarkers Market - India
  - 10.5.7.1. India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.8. Biomarkers Market - Malaysia
  - 10.5.8.1. Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.9. Biomarkers Market - Japan
  - 10.5.9.1. Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.10. Biomarkers Market - Indonesia
  - 10.5.10.1. Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.11. Biomarkers Market - South Korea
  - 10.5.11.1. South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.12. Biomarkers Market - Australia
  - 10.5.12.1. Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.5.13. Biomarkers Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
10.6. Biomarkers Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.6.6. Biomarkers Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.6.7. Biomarkers Market - UAE
  - 10.6.7.1. UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.6.8. Biomarkers Market - Israel
  - 10.6.8.1. Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.6.9. Biomarkers Market - South Africa
  - 10.6.9.1. South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.6.10. Biomarkers Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
10.7. Biomarkers Market - Latin America
- 10.7.1. Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.7.6. Biomarkers Market - Mexico
  - 10.7.6.1. Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.7.7. Biomarkers Market - Brazil
  - 10.7.7.1. Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.7.8. Biomarkers Market - Argentina
  - 10.7.8.1. Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
- 10.7.9. Biomarkers Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Abbott Laboratories
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Agilent Technologies, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. BioMerieux SA
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Bio-Rad Laboratories, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Charles River Laboratories International, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Eurofins Scientific SE
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. F. Hoffmann-La Roche Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Guardant Health, Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Illumina, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Merck KGaA
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. QIAGEN N.V.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Revvity, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development